We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine Protein Test Can Predict Dementia Risk

By LabMedica International staff writers
Posted on 26 Sep 2025

Dementia remains one of the most pressing health challenges worldwide, with age as the greatest risk factor. More...

Increasingly, research suggests that diseases in other organs, such as the kidneys, may play a role in its development. Identifying markers that link kidney health to brain function could provide an early warning for cognitive decline. Now, a new study has shown that a common protein found in urine may indicate an increased risk of developing dementia later in life.

The study, conducted by researchers at Karolinska Institutet (Stockholm, Sweden), investigated the role of albuminuria—an abnormal condition where the protein albumin leaks into urine. Normally, healthy kidneys filter waste products while keeping essential proteins like albumin in the blood. Elevated albumin levels indicate kidney damage and, according to this research, may also reflect vascular changes that predispose individuals to dementia.

Researchers followed 130,000 adults aged over 65 in Stockholm who were free of dementia at baseline. Over four years, 7 percent developed dementia. After adjusting for kidney function and other health factors, results showed that those with moderate albuminuria (30–299 mg/g) had a 25 percent higher risk of dementia, while those with high levels (≥300 mg/g) had a 37 percent greater risk compared to participants with normal albumin levels.

The association was particularly strong for vascular dementia, often caused by stroke, high blood pressure, diabetes, or vascular disease, and for mixed dementia, which combines vascular and Alzheimer’s features. The findings, published in the Journal of Internal Medicine, highlight how kidney dysfunction may mirror damage in the brain’s small vessels, influencing the blood-brain barrier and increasing the risk of harmful protein buildup linked to dementia.

The study underscores the potential of routine screening for albuminuria in older adults and in patients with conditions like hypertension, diabetes, cardiovascular disease, or kidney disease. Detecting the condition early could allow for preventive interventions to reduce or delay dementia onset. Researchers suggest integrating this simple urine test into dementia risk assessments to improve outcomes and reduce disease burden.

"These results underscore the importance of routine screening for albuminuria as part of early dementia risk assessment, especially in patients with high blood pressure, diabetes, cardiovascular disease, or kidney disease,” said Hong Xu, assistant professor at Karolinska Institutet and last author of the study. “Early detection of albuminuria could potentially delay or prevent the onset of dementia."

Related Links:
Karolinska Institutet


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.